Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 19, 2010, Pages 8730-8735

  Meuter, Simone ^a,b   Eberl, Matthias ^a   Moser, Bernhard ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

T cells; Antigen cross presentation; Dendritic cells; Influenza virus

Indexed keywords

AMINOPEPTIDASE; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ARTICLE; CD4 CD8 RATIO; CELL SURVIVAL; CONTROLLED STUDY; CROSS PRESENTATION; CYTOSOL; DENDRITIC CELL; HUMAN; HUMAN TISSUE; INFLUENZA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; T LYMPHOCYTE; VIRUS PARTICLE;

ACIDS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; CATTLE; CROSS-PRIMING; CYTOSOL; DENDRITIC CELLS; ENDOCYTOSIS; ENDOSOMES; HUMANS; INFLUENZA A VIRUS; MONOCYTES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES; VIRION; VIRUS INACTIVATION;

ORTHOMYXOVIRIDAE;

EID: 77952691736     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1002769107     Document Type: Article

References (39)

1. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA (2005) Mechanisms of MHC class I - restricted antigen processing and cross-presentation. Immunol Rev 207: 145-157. (Pubitemid 41415014)
2. Lin ML, Zhan Y, Villadangos JA, Lew AM (2008) The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol Cell Biol 86:353-362. (Pubitemid 351667998)
3. Villadangos JA, Schnorrer P (2007) Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7:543-555.
4. Vyas JM, Van der Veen AG, Ploegh HL (2008) The known unknowns of antigen processing and presentation. Nat Rev Immunol 8:607-618.
5. Di Pucchio T, et al. (2008) Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol 9:551-557. (Pubitemid 351560524)
6. Hoeffel G, et al. (2007) Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27:481-492. (Pubitemid 47418679)
7. Schnurr M, et al. (2005) Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood 105:2465-2472. (Pubitemid 40387047)
8. Villadangos JA, Young L (2008) Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29:352-361.
9. Nagata Y, et al. (2002) Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. Proc Natl Acad Sci USA 99:10629-10634.
10. + alphabeta T cell responses. Proc Natl Acad Sci USA 106:2307-2312.
11. Schnurr M, et al. (2009) ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J Immunol 182:1253-1259.
12. Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human gammadelta T cells. Science 309:264-268. (Pubitemid 40967855)
13. + T-cell responses to subdominant Epstein-Barr virus epitopes: Potential for immunotherapy of cancer. J Immunother 32:310-321.
14. Wu Y, et al. (2009) Human γδ T cells: A lymphoid lineage cell capable of professional phagocytosis. J Immunol 183:5622-5629.
15. Hayday AC (2009) Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 31:184-196.
16. Morita CT, Jin C, Sarikonda G, Wang H (2007) Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: Discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215:59-76. (Pubitemid 46212230)
17. Carding SR, Egan PJ (2002) Gammadelta T cells: Functional plasticity and heterogeneity. Nat Rev Immunol 2:336-345. (Pubitemid 37328756)
18. Moser B, Eberl M (2007) Gammadelta T cells: Novel initiators of adaptive immunity. Immunol Rev 215:89-102. (Pubitemid 46212232)
19. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 103:10729-10734.
20. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975-1028. (Pubitemid 40563191)
21. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES (2005) Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630-1634. (Pubitemid 40354746)
22. Savina A, et al. (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126:205-218. (Pubitemid 44026552)
23. Monu N, Trombetta ES (2007) Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules. Curr Opin Immunol 19:66-72. (Pubitemid 46073703)
24. Saveanu L, et al. (2009) IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325:213-217.
25. + dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci USA 105:3029-3034.
26. + cytolytic T cell responses. J Exp Med 182:1663-1671.
27. Cheng L, et al. (2008) Mouse γδ T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J Neuroimmunol 203:3-11.
28. Takamatsu HH, Denyer MS, Wileman TE (2002) A sub-population of circulating porcine gammadelta T cells can act as professional antigen-presenting cells. Vet Immunol Immunopathol 87:223-224.
29. + alphabeta T cells. J Leukoc Biol 63:707-714.
30. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
31. Savina A, Amigorena S (2007) Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 219:143-156. (Pubitemid 47390005)
32. van Montfoort N, et al. (2009) Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci USA 106:6730-6735.
33. Shen H, et al. (2006) Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117:78-88.
34. Holtmeier W, Kabelitz D (2005) Gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy 86:151-183.
35. Poccia F, et al. (2005) Antiviral reactivities of gammadelta T cells. Microbes Infect 7: 518-528.
36. Shao L, et al. (2009) Expansion, re-expansion and recall-like expansion of Vγ2Vδ2 T cells with enhanced effector function in smallpox vaccination and monkeypox virus infection. J Virol 83:11959-11965.
37. Qin G, et al. (2009) Phosphoantigen-expanded human γδ T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis 200:858-865.
38. Brandes M, et al. (2003) Flexible migration program regulates γδ T-cell involvement in humoral immunity. Blood 102:3693-3701.
39. Altan N, Chen Y, Schindler M, Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187:1583-1598. (Pubitemid 28235100)